Hepatocellular carcinoma after direct‐acting antiviral drug treatment in patients with hepatitis C virus

BACKGROUND AND AIM: Given the use of direct‐acting antivirals (DAAs) to treat hepatitis C virus (HCV), their effects on hepatocarcinogenesis should be determined. METHODS: This study enrolled 349 patients with HCV who underwent DAA treatment at our hospital between 2014 and 2018. Their median age wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kogiso, Tomomi, Sagawa, Takaomi, Kodama, Kazuhisa, Taniai, Makiko, Katagiri, Satoshi, Egawa, Hiroto, Yamamoto, Masakazu, Tokushige, Katsutoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386743/
https://www.ncbi.nlm.nih.gov/pubmed/30834341
http://dx.doi.org/10.1002/jgh3.12105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386743/
https://www.ncbi.nlm.nih.gov/pubmed/30834341
http://dx.doi.org/10.1002/jgh3.12105

Ejemplares similares